NON-CLINICAL SAFETY EVALUATION OF A NOVEL THERAPEUTIC VACCINE FOR PEANUT ALLERGY

被引:0
|
作者
Kirk, S.
Rashid, H.
Demisse, E.
Wilson, T.
Heath, M.
De-Kam, P.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P170
引用
收藏
页码:S61 / S61
页数:1
相关论文
共 50 条
  • [1] Non-clinical vaccine safety assessment
    Verdier, F
    TOXICOLOGY, 2002, 174 (01) : 37 - 43
  • [2] Considerations for non-clinical safety studies of therapeutic peptide vaccines
    Matsumoto, Mineo
    Komatsu, Shinichi
    Tsuchimoto, Mayumi
    Matsui, Hajime
    Watanabe, Kazuto
    Nakamura, Kazuichi
    Amakasu, Kohei
    Ito, Kanako
    Fueki, Osamu
    Sawada, Jun-ichi
    Maki, Kazushige
    Onodera, Hiroshi
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2014, 70 (01) : 254 - 260
  • [3] Designing non-clinical safety evaluation programmes for monoclonal antibodies for therapeutic use: A personal view
    Bugelski, PJ
    SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 103 - 114
  • [4] Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies
    Brennan, FR
    Dougan, G
    VACCINE, 2005, 23 (24) : 3210 - 3222
  • [5] Peanut and soy allergy: a clinical and therapeutic dilemma
    Sicherer, SH
    Sampson, HA
    Burks, AW
    ALLERGY, 2000, 55 (06) : 515 - 521
  • [6] Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan
    Hebar, Alexandra
    Koller, Christiane
    Seifert, Jan-Marcus
    Chabicovsky, Monika
    Bodenteich, Angelika
    Bernkop-Schnuerch, Andreas
    Grassauer, Andreas
    Prieschl-Grassauer, Eva
    PLOS ONE, 2015, 10 (04):
  • [7] Designing non-clinical safety evaluation programmes: The view of the clinician
    Lipani, J
    SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 1 - 6
  • [8] Points to consider on the non-clinical safety evaluation of anticancer drugs
    Nakae, Dai
    Onodera, Horoshi
    Fueki, Osamu
    Urano, Tsutomu
    Komiyama, Noriyuki
    Sagami, Fumio
    Kai, Shuichi
    Nishimura, Chihiro
    Inoue, Tohru
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2008, 33 (02): : 123 - 126
  • [9] Designing non-clinical safety evaluation programmes: The view of the toxicologist
    Dempster, M
    SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 7 - 15
  • [10] Non-clinical Safety Evaluation of Biotherapeutics - Challenges, Opportunities and new Insights
    Blaich, Guenter
    Baumann, Andreas
    Kronenberg, Sven
    de Haan, Lolke
    Ulrich, Peter
    Richter, Wolfgang F.
    Tibbitts, Jay
    Chivers, Simon
    Tarcsa, Edit
    Caldwell, Robert
    Crameri, Flavio
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2016, 80 : S1 - S14